1. Vaughan Williams, E. M. (1970). Classification of antiarrhythmic drugs. In Sandoe, E., Flensted-Jensen, E. and Olesen, K. H. (eds.) Symposium on Cardiac Arrhythmias. pp. 449 – 492 ( Sodertalje, Sweden: Astra AB )
2. Singh, B. N. and Vaughan Williams, E. M. (1972). A fourth class of antiarrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials and on other features of cardiac function. Cardiovasc. Res., 6, 109 – 14
3. Singh, B.N. and Hauswirth, O. (1974). Comparative mechanism of action of antiarrhythmic drugs. Am. Heart
J, 87, 367 – 82
4. Millar, J. S. and Vaughan Williams, E. M. (1981). Anion antagonism - A fifth class of antiarrhythmic action? Lancet, I, 1291 – 2
5. Touboul, P. and Morena, H. (1979). Electrophysiological effects of antiarrhythmic drugs. In Puech, P. and Siama, R. (eds.) The Cardiac Arrhythmias by the Arrhythmia Working Group of the French Cardiac Society, pp. 245 – 51. ( Paris: Corbiere and Roussel )